61.
 J, Berkman ND,
9. Sterne JA, Hernán MA, Reeves BC, Savovic
Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in
non-randomised studies of interventions. BMJ 2016;355:i4919.
 J, Page MJ, Elbers RG, Blencowe NS, Boutron I,
10. Sterne JA, Savovic
et al. RoB 2: a revised tool for assessing risk of bias in randomised
trials. BMJ 2019;366:I4898.
11. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al.
The Newcastle-Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta-analyses. Oxford; 2000.
12. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ,
Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:
529-36.
13. Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C.
Assessing bias in studies of prognostic factors. Ann Intern Med
2013;158:280-6.
_
14. Schünemann H, Brozek
J, Guyatt G, Oxman A. The GRADE handbook. UK: Cochrane Collaboration London; 2013.
15. Dewidar O, Lotﬁ T, Langendam MW, Parmelli E, Saz Parkinson Z,
Solo K, et al. Good or best practice statements: proposal for the
operationalisation and implementation of GRADE guidance. BMJ
Evid Based Med 2023;28:189-96.
16. Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, et al.
ESVM Guideline on peripheral arterial disease. Vasa 2019;48:1-79.
1